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ABSTRACT 
Milk oligosaccharides contribute to the development of the intestinal environment by 
acting as decoy receptors for pathogens and as prebiotics, which promote the colonization 
of commensal bacteria. Here, using 2,3- and 2,6-sialyltransferase-deficient mice, we 
investigated the role of the sialylated milk oligosaccharides sialyl(α2,3)lactose and 
sialyl(α2,6)lactose on mucosal immunity. The exposure of newborn mice to milk containing 
or deficient in sialyllactose had no impact on the development of mucosal leukocyte 
populations. However, when challenged by dextran sulfate sodium (DSS) in drinking water, 
adult mice that had been fostered on sialyl(α2,3)lactose-deficient milk were more resistant 
to colitis compared to mice fostered on normal milk or sialyl(2,6)lactose-deficient milk. 
Analysis of intestinal microbiota showed different colonization patterns depending on the 
presence or absence of sialyl(α2,3)lactose in the milk. Germ-free mice reconstituted with 
intestinal microbiota isolated from mice fed on sialyl(α2,3)lactose-deficient milk were more 
resistant to DSS-induced colitis than germ-free mice reconstituted with standard intestinal 
microbiota. Thus, exposure to sialyllactose during infancy affects bacterial colonization of 
the intestine, which influences the susceptibility to DSS-induced colitis in adult mice. 
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INTRODUCTION 
Oligosaccharides represent a major fraction of milk constituents. Unique among mammals, 
human milk contains a tremendous diversity of oligosaccharide structures, which are 
shaped by extension of lactose through glycosyltransferase enzymes in the mammary gland 
(Egge, 1993). The most abundant structures are the trisaccharides produced by addition of 
fucose or sialic acid to lactose. Whereas fucosylated oligosaccharides are missing from most 
mammalian milks, sialylated oligosaccharides are more widely distributed (Urashima et al., 
2001). Since milk oligosaccharides are neither digested, nor absorbed in the small intestine 
(Brand Miller et al., 1995), they have been suggested to contribute to the development of 
the infant gastrointestinal tract and its colonization by commensal bacteria (Frank and 
Pace, 2008; Savage, 1977). 
Milk oligosaccharides influence the development of the intestinal microbiota by acting as 
selective nutrients, which support the proliferation of specific bacterial groups (Gibson and 
Roberfroid, 1995). The prebiotic action of milk oligosaccharides has been demonstrated by 
comparing the intestinal microbiota of infants fed on oligosaccharide-rich breast milk and 
infants fed on formula (Harmsen et al., 2000). Furthermore, considering the structural 
similarity of milk oligosaccharides with cell surface glycans, milk oligosaccharides can 
function as soluble receptors, thereby preventing the attachment of pathogenic bacteria to 
intestinal epithelial cells (Newburg, 2009). 
Commensal bacteria are mainly found in the large intestine, consisting predominantly of the 
phyla Firmicutes and Bacteroidetes (Eckburg et al., 2005). Firmicutes themselves are 
composed of two major clostridial groups, namely the clostridial cluster IV and clostridial 
cluster XIVa, which comprises Lachnospiraceae. The density and diversity of the intestinal 
microbiota are highly complex. Culture-independent methods have allowed to estimate the 
presence of 500-1000 different species and over 7000 strains in the human gastrointestinal 
tract (Dethlefsen et al., 2007; Ley et al., 2006). Commensal bacteria are indispensible for the 
proper development of the mucosal immune system. In addition to morphological 
development of immune compartments, bacterial colonization initiates antibody 
production (Macpherson and Harris, 2004) and the production of antimicrobial proteins 
such as defensins (Falk et al., 1998). Bacterial cell wall components have also been shown to 
regulate CD4+ T helper cell activity in the lamina propria (Mazmanian et al., 2008). On the 
other hand, a defect of the innate immune system has been shown to affect the composition 
of the intestinal microbiota in mice and thereby contributes to metabolic imbalance (Vijay-
Kumar et al., 2010). In humans, similar relationships have been established between the 
intestinal microbiota and energy balance, thus leading to the definition of microbiomes 
typical for disorders such as obesity (Turnbaugh et al., 2006). 
Prebiotic oligosaccharides have been claimed to reduce the susceptibility to allergies in 
infants (Hoffen et al., 2009; Moro et al., 2006) and shown to influence the immune response 
to vaccination in mice (Vos et al., 2007). However, the mechanisms underlying the 
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regulatory action of oligosaccharides remain largely unknown. Considering the structural 
complexity of human milk oligosaccharides, the mouse with its reduced range of milk 
oligosaccharides (Prieto et al., 1995) enables addressing the functional impact of specific 
oligosaccharides on mucosal immunity in vivo. In the present study, we have studied the 
impact of sialylated oligosaccharides using sialyltransferase-knockout mice deficient for 
these milk oligosaccharides. The fostering of newborn mice by normal or sialyllactose-
deficient mothers allowed demonstrating the importance of this type of milk 
oligosaccharides on the colonization of intestinal bacteria and on the susceptibility to an 
experimental colitis model. 
 
RESULTS 
The sialyltransferase enzymes St6gal1 and St3gal4 are responsible for the 
production of sialyllactose in mouse milk. 
The composition of mouse milk oligosaccharides is limited to sialyllactose with only traces 
of fucosylated lactose (Kuhn, 1972; Prieto et al., 1995). This low structural complexity 
makes the mouse a suitable model to investigate the role of these specific milk 
oligosaccharides on mucosal immunity. Because multiple 2,3 and 2,6 sialyltransferase 
enzymes (Harduin-Lepers et al., 2001) could be responsible for the production of 
sialyllactose, we have first examined the expression of these genes in the lactating 
mammary gland. The mRNA levels of the 2,3 sialyltransferase genes St3gal1 to St3gal6 
and of the two 2,6 sialyltransferase genes St6gal1 and St6gal2 were determined by real-
time PCR . The expression of the St6gal1 gene was induced up to 20-fold during lactation, 
suggesting this sialyltransferase may account for the biosynthesis of sialyl(2,6)lactose 
(6SL) (Fig. 1) and thus confirming a previously published observation (Dalziel et al., 2001). 
Among 2,3 sialyltransferase genes, the expression of St3gal1 and St3gal4 were induced by 
3- and 4-fold during lactation, respectively (Fig. 1). The three St6gal1, ST3gal1 and St3gal4 
represented also the most abundant sialyltransferase transcripts in lactating mammary 
gland when mRNA levels were normalized to GAPDH (Fig. S1). 
To confirm the involvement of the St3gal1, St3gal4 and St6gal1 sialyltransferases in the 
production of milk sialyllactose, the oligosaccharide composition of milk isolated from 
St3gal1, St3gal4 and St6gal1 sialyltransferase-deficient mice was determined by pulsed 
amperometry-HPAEC. Milk isolated from St3gal1-/- mice showed unaffected or rather 
increased levels of both sialyl(2,3)lactose (3SL) and 6SL when compared to the levels 
measured in wild-type (WT) mice by day two of lactation (Fig. 2A). The analysis of 
oligosaccharides in milk from St3gal4-/- mice showed a strong decrease of 3SL, indicating 
that this sialyltransferase accounts for the bulk of 3SL production. The importance of 
St6gal1 in the production of 6SL was confirmed by the absence of this oligosaccharide in the 
milk isolated from St6gal1-/- mice (Fig. 2A). The impact of St3gal4 on 3SL production was 
  
4 
 
investigated in more details by measuring sialyllactose levels across lactation. In WT mice, 
3SL levels peaked in the first week of lactation and slowly decreased until day 20, where 
only minor concentrations were detected. By contrast, 6SL levels showed only a modest 
increase by mid-lactation (Fig. 2B). The 3SL peak by the first week of lactation was absent 
in the milk of St3gal4-/- mice and 3SL levels remained low across lactation, thus 
demonstrating the importance of St3gal4 for the biosynthesis of 3SL (Fig. 2C). The identity 
of 3SL and 6SL and exact structure of sialic acid in mouse milk were also analyzed after 
release by neuraminidase treatment. We did find that milk sialyllactose was exclusively 
composed of N-acetylneuraminic acid since no N-glycolylneuraminic acid could be detected 
(Fig. S2). 
Feeding with milk deficiency in 3SL increases the resistance of mice to dextran 
sulfate sodium-induced colitis 
The role of milk 3SL and 6SL onto the development of the mucosal immune system was 
addressed by feeding WT and St3gal4-/- newborn mice with normal or with 3SL-deficient 
milk as achieved by cross-fostering litters with WT and St3gal4-/- mothers. The same cross-
fostering approach was applied to study the role of 6SL. Leukocyte populations and IgA 
secretion were determined in three-, six- and twelve-week old mice by flow cytometry and 
enzyme-linked immunosorbent assay, respectively. The T-cell specific markers TCRαβ/γδ, 
CD4, CD8 and CD8αα/αβ were measured in WT, St3gal4-/-, St6gal1-/- and correspondingly 
cross-fostered mice. No differences were noticeable for leukocyte populations and IgA 
secretion (Fig. S3), indicating that neither the feeding with sialyllactose-deficient milk, nor 
the disruption of the St3gal4 and St6gal1 genes had any impact on the maturation of 
intestinal leukocytes. 
In a second approach, we have addressed whether feeding with 3SL- and 6SL-deficient milk 
affected the response of mice to an intestinal challenge. At seven weeks of age, mice were 
exposed to dextran sulfate sodium (DSS) in drinking water for five days. DSS impairs the 
integrity of intestinal barrier, thereby inducing an acute colitis (Okayasu I, 1990). WT mice 
responded strongly to the treatment as shown by a loss of body weight of 17% by day 
seven. By contrast, St3gal4-/- mice were more resistant to DSS as they lost only 5% of their 
body weight by day seven (Fig. 3A). WT mice that were cross-fostered and fed with 3SL-
deficient milk sustained the DSS treatment better than those fed with normal milk, as 
shown by a reduced loss of body weight of 8%. Correspondingly, St3gal4-/- mice fed with 
normal milk were more susceptible to DSS-induced colitis than littermates fed with 3SL-
deficient milk (Fig. 3A). DSS-induced colitis in St6gal1-/- mice lead to a similar disease as 
found in WT mice. Accordingly, cross-fostering experiments with normal and 6SL-deficient 
milk had no impact on the susceptibility to acute colitis (Fig. S4). We therefore focused on 
the investigation of 3SL in colitis development. 
The severity of colitis was also registered by measuring colon length, epithelial 
permeability and histology. At day seven, colon length was shortened by 20-25% in WT 
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mice, whereas it was shortened by 10% in St3gal4-/- mice (Fig. 3B). Cross-fostered mice 
showed a degree of colon shortening that matched the loss of body weight. WT mice fed 
with 3SL-deficient milk showed only a 10% colon shortening and St3gal4-/- mice fed with 
normal milk showed a more pronounced colon shortening (Fig. 3B). A similar picture was 
obtained by examining epithelial permeability in the intestine. DSS treatment increased 
epithelial leakiness in WT mice but not in St3gal4-/- mice. The finding was reversed when 
looking at cross-fostered WT and St3gal4-/- mice fed with 3SL-deficient and normal milk, 
respectively (Fig. 3C). Histological examination of DSS-treated mice revealed severe 
inflammation with massive infiltration of leukocytes into the mucosa, and loss of entire 
crypts and surface epithelium, particularly in the middle to distal colon at day 7 for WT and 
cross-fostered St3gal4-/- mice (Fig. 3D). St3gal4-/- mice were less affected by DSS treatment 
as focal inflammation was less pronounced. The extent of tissue damage and leukocyte 
infiltration in WT and St3gal4-/- mice correlated with the exposure to milk 3SL during 
feeding. The impact of cross fostering on the colitis of WT and St3gal4-/- mice was 
confirmed by grading the extent of epithelial damage and leukocyte infiltration in the 
medial and distal colon (Hausmann et al., 2007). The colitis score of WT mice fed with 3SL-
deficient milk showed a non-statistically significant lower trend than that of WT mice fed 
with normal milk. Correspondingly, the score of St3gal4-/- mice fed with normal milk tended 
to be higher, yet non-statistically significantly, than that of St3gal4-/- mice fed with 3SL-
deficient milk (Fig. 3E). 
To better characterize the inflammatory response, we first measured the expression of 
chemokine and inflammatory marker genes in colon tissue on day seven of DSS treatment. 
Whereas the levels of TNF and IL-1 expression were only partially altered by milk 
feeding history, IL-6 expression was induced 59-fold in in St3gal4-/- mice, which had been 
fed with normal milk, when compared to about 25-fold increase observed in mice exposed 
to 3SL-deficient milk (Fig. 4). WT mice exposed to normal milk during lactation contained 
elevated levels of IL-6 that was again reduced in mice previously exposed to 3SL-deficient 
milk. The expression of the chemokines CCL2, CCL5 and CXCL-1 was elevated in mice with 
severe inflammation and correlated with the exposure to normal milk. Similarly, the 
expression of other inflammatory markers, such as IL-12, IFN- and COX-2 was also 
increased in DSS-treated mice, yet to lower levels (Fig. 4).  
The extent and types of cells infiltrating the inflamed colons were analyzed by flow 
cytometry in WT, St3gal4-/- mice and correspondingly cross-fostered mice. By day 5, 27 to 
40% of cells recovered from the lamina propria were CD45+ (Fig. 5A). By day 7, additional 
5-10% CD45-positive cells were detected. Leukocyte infiltration was highest in mice with 
normal milk feeding history, but infiltration was only slightly decreased in mice that had 
been fed with 3SL-deficient milk (Fig. 5B). The CD45+ cells were identified as B cells (68%, 
CD19+) and granulocytes (20%, Ly6G+) with a minor population of T cells (7%, CD3+), 
inflammatory monocytes (6%, Ly6C+ high) and macrophages (7%, F4/80+) (Fig. 5C, S5). 
The number of Th1 and Th17 cells, as assessed by respective IFN and IL17 detection in 
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CD4+ T cells, was equal in WT mice by day 7 of DSS treatment, whereas a 3-fold decrease of 
Th1 against Th17 cells was found in St3gal4-/- mice (Fig S5). The main increase in 
infiltrating leukocytes was due to Ly6C+ inflammatory monocytes, as previously observed 
in IBD patients (Flanagan et al., 2008). To determine whether the genotype of the infiltrating 
leukocytes affected the extent of DSS-induced colitis, we subjected irradiated WT mice 
transplanted with St3gal4-/- bone marrow and irradiated St3gal4-/- mice transplanted with 
WT bone marrow to DSS treatment. After transplantation, mice were given seven weeks to 
recover from mucosal injury sustained during irradiation before being subjected to DSS 
treatment. WT mice bearing immune cells from St3gal4-/- mice rapidly developed colitis and 
lost 15% of body weight whereas St3gal4-/- mice bearing WT immune cells did only lose 3% 
of weight loss at the same time point (Fig. 5D). The fact that St3gal4-/- mice remained 
resistant to DSS treatment regardless of the genotype of infiltrating leukocytes, i.e. WT or 
St3gal4-/-, established that the resistance to DSS was inherent to the intestinal tissue and 
not affected by the deletion of St3gal4 in blood leukocytes. 
Feeding with 3SL-deficient milk modifies the bacterial colonization of the mouse 
intestine 
We did show so far that the exposition to milk in the first three weeks of life had an impact 
on the susceptibility to DSS-induced colitis tested in adult mice. Considering the known 
effect of milk oligosaccharides as prebiotics (Bode, 2009), we addressed whether the 
presence or absence of 3SL affected the composition of the intestinal microbiota and 
thereby the outcome of DSS-induced colitis. To address the first point, we fingerprinted the 
intestinal microbiota of WT, St3gal4-/- and cross-fostered mice by temporal temperature 
gradient gel electrophoresis (TTGE) and by real-time PCR. TTGE fingerprints from each six 
mice of each group were analyzed at three, six (Fig. 6A) and twelve weeks of age. Despite 
internal differences within groups, cluster analysis indicated a higher degree of similarity 
within than between these groups. A specific band, identified by sequencing as representing 
a Ruminococcaceae species (Fig. S6), was only detectable by TTGE in the microbiota of mice 
exposed to 3SL, namely in WT mice and in St3gal4-/- mice fed with WT milk (Fig. 6A). The 
sequence obtained from the TTGE band indicated that the Ruminococcaceae species was 
very close to Ruminococcaceae from the clostridial cluster IV, yet different from the species 
known to date. By comparison, the presence or absence of 6SL as tested with St6gal1-/- mice 
did not affect the occurrence of the Ruminococcaceae in the intestinal microbiota (Fig. S7), 
indicating that these bacteria require 3SL for gut colonization. 
The diversity of the intestinal microbiota was also determined during DSS-induced colitis. A 
lower amount of bands on the gels were detected in DSS-treated mice compared to healthy 
animals indicating a decrease of microbial diversity (Fig. 6B). The band distribution on the 
gel was also shifted in mice treated with DSS, showing a change in microbial composition. 
Interestingly the Ruminococcaceae-related band remained unchanged during colitis. The 
intestinal microbiota DNA samples investigated by TTGE (Fig. 6A, B) were also tested by 
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real-time PCR analysis to determine the distribution of the five phylogenic groups 
Enterobacteriaceae, Lachnospiraceae, clostridial cluster IV, Bacteroidetes and 
Lactobacillaceae in WT, St3gal4-/- and cross-fostered mice. This analysis confirmed that 3SL 
deficiency in the milk affected the colonization of clostridial cluster IV bacteria (Fig. 7A). 
However, during DSS-induced colitis, the previous exposure to 3SL in milk influenced the 
relative composition of Enterobacteriaceae and the clostridial cluster IV to total bacteria. 
Enterobacteriaceae and the clostridial cluster IV were more abundant in WT and cross-
fostered St3gal4-/- mice after DSS treatment (Fig. 7B).  
Considering the differential detection of a Ruminococcaceae species by TTGE analysis and 
the fact that several Ruminococcaceae are part of the clostridial cluster IV (Van Dyke and 
McCarthy, 2002), we have measured the abundance of these bacteria using PCR primers 
that specifically target 16S rDNA from Ruminococcus genera (Fig. S8). In agreement with the 
TTGE data, the Ruminococcaceae species was more abundant in mice that had been exposed 
to 3SL containing milk, i.e. in WT and cross-fostered St3gal4-/- mice (Fig. 7C). The treatment 
with DSS did not alter the levels of Ruminococcaceae, thereby confirming the TTGE findings 
(Fig. 6B). 
Microbiota isolated from mice fed with 3SL-deficient milk increase the resistance of 
reconstituted germ-free mice to DSS-induced colitis  
To demonstrate that the effect of 3SL-deficiency towards DSS treatment was mediated by 
selective bacterial colonization of the intestine, we have reconstituted germ-free mice with 
intestinal microbiota isolated from the cecum of WT and St3gal4-/- mice. Colonization 
success was confirmed by TTGE analysis of fecal pellets two weeks after reconstitution. The 
microbiota from WT mice included the Ruminococcus-related specific band, whereas the 
microbiota from St3gal4-/- mice lacked this major band (Fig. 8A). The mice with 
reconstituted microbiota were then subjected to DSS treatment by twelve weeks of age. The 
mice with the WT derived microbiota showed a progressive loss of body weight similar to 
WT mice, reaching 82% of their initial body weight by day seven (Fig. 8B). By contrast, the 
mice with the St3gal4-/- derived microbiota showed a moderate weight loss to 90% of initial 
body weight, thus demonstrating that the composition of the intestinal microbiota had a 
direct influence on the susceptibility to DSS-induced colitis. 
 
DISCUSSION 
The present study demonstrated the impact of the milk sialyllactose 3SL on the colonization 
of the murine intestinal microbiota and thereby on the susceptibility to DSS-induced colitis. 
The application of the cross-fostering setup between WT and St3gal4-/- mice demonstrated 
for the first time that a single oligosaccharide structure influences microbial composition in 
vivo. The different abundance of specific bacterial groups like Ruminococcaceae in mice fed 
with normal or 3SL-deficient milk correlated with the susceptibility to DSS-induced colitis. 
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The first question arising when considering the model investigated is whether the 
oligosaccharide 3SL exerts regulatory functions on the mucosal immune system, thereby 
influencing the immune response to DSS exposure. Our survey of leukocyte populations did 
not reveal any differences between WT, St3gal4-/- and cross-fostered mice, thus speaking 
against such an immunoregulatory effect of 3SL. Furthermore, the bone marrow 
transplantation between WT and St3gal4-/- mice showed that the susceptibility to DSS did 
not correlate with the genotype of leukocytes. Finally, the differential susceptibility of 
reconstituted germ-free mice to DSS demonstrated that the effect of 3SL-deficient milk was 
mediated by microbiota and not by the mucosal immune system.  
The exposure to 3SL during lactation could influence the colonization of intestinal bacteria 
by affecting their adhesion to the intestinal epithelium or by serving as nutrients for specific 
groups of bacteria. Milk 3SL could impair the attachment of bacteria binding to sialylated 
surfaces (Sakarya et al., 2003) or induce phase variation, thereby decrease type 1 fimbriae 
expression on some bacteria (Sohanpal et al., 2004). However, we could not address such 
an effect of 3SL on the colonization of Ruminococcaceae, since we did not succeed yet at 
isolating this bacterial group in culture. Alternatively, 3SL could be used as a carbon and 
nitrogen source, which would facilitate the proliferation of bacteria capable of metabolizing 
sialic acid, as shown for the intestinal colonization of E. coli and V. cholera (Almagro-
Moreno and Boyd, 2009b; Chang et al., 2004). Noteworthy, the Nan-cluster of genes 
required for the catabolism of sialic acid is found in several pathogenic and commensal 
bacteria including Ruminococcus gnavus (Almagro-Moreno and Boyd, 2009a). Thus the 
selective colonization of Ruminococcaceae in the presence of 3SL might be mediated 
through their ability to use 3SL for energy gain. 
The gram-positive Ruminococcaceae are obligate anaerobes that are commonly found in the 
colon of mammals including mice and humans (Collins et al., 1994). Ruminococcaceae are 
known to ferment polysaccharides like cellulose and starch (Herbeck and Bryant, 1974; 
Leitch et al., 2007; Wang et al., 1997). The correlation between the abundance of the 
Ruminococcus-related species and the susceptibility to DSS-induced colitis suggests that this 
bacterium may have a pro-inflammatory action. The fact that Ruminococcaceae have been 
found enriched in patients with inflammatory bowel disease (Andoh et al., 2007; Martinez-
Medina et al., 2006; Pirindiville et al., 2004) supports their potential role as pro-
inflammatory bacteria. Moreover, the intestinal colonization of Ruminococcaceae may 
impair the settlement of other bacterial groups, which are known to attenuate the extent of 
the inflammatory response (Im et al., 2009; Kumar et al., 2008) 
At the present stage, it is not possible to demonstrate a direct relationship between the 
intestinal abundance of Ruminococcaceae and the severity of DSS-induced colitis. The 
isolation and culture of Ruminococcaceae in vitro would allow the selective reconstitution of 
germ-free mice with these bacteria and subsequently to address the susceptibility of the 
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mice to DSS treatment. We are currently trying to enrich for Ruminococcaceae on 3SL-
containing media in order to assess their exact role in the development of colitis.  
Our study has demonstrated that the exposure to a single milk oligosaccharide structure 
can significantly influence intestinal bacterial colonization and thereby affect the 
susceptibility of the host to DSS-induced colitis. The fact that mice fed with 3SL-deficient 
milk were more resistant to DSS treatment is somehow paradoxical, considering that this 
oligosaccharide is evolutionary conserved in most mammals. Although 3SL has a pro-
inflammatory effect in the DSS model, it can be assumed that 3SL may mediate protective 
actions, as for example by preventing the adhesion of pathogenic viruses and bacteria 
during infancy. Further, the 3SL dependent microbiota might confer an evolutionary 
advantage by promoting an inflammatory defense reaction upon an infection challenge. The 
fact that 3SL levels in milk are elevated in the first days postpartum and strongly decrease 
until weaning may indicate the need for a balanced availability of the oligosaccharide in the 
developing gastrointestinal tract. The study of additional immunological challenges and 
infectious models in sialyltransferase-/- mice will further clarify the biological importance of 
sialylated milk oligosaccharides in the physiology of the gastrointestinal tract. 
 
MATERIALS AND METHODS 
Mouse models - Sialyltransferase St6gal1-/- (Hennet et al., 1998), St3gal1-/- (Priatel et al., 
2000) and St3gal4-/- (Ellies et al., 2002) were  provided by Dr. Jamey Marth (University of 
California Santa Barbara, USA). All mice were in the C57Bl/6 background. Sialyltransferase-
deficient and WT control mice were housed in light-cycled and climate-controlled rooms. 
All experiments were performed in compliance with the Swiss Animal Protection Ordinance 
and approved by the Veterinary Office of the Canton of Zürich, Switzerland. Synchronized 
matings were setup for sialyltransferase and WT control mice to allow the exchange of 
newborn mice for cross-fostering experiments. To this end both the mothers and the litter 
of the other genotype were transferred to new cages including parts of the mother’s nests. 
Sialyltransferase gene expression in mammary glands - Commercial RNA (Axxora Ltd., UK) 
isolated from mammary glands of virgin mice and mice after one and two weeks 
postpartum and three days post weaning was used to monitor sialyltransferase expression 
profiles by real-time PCR using a SybrGreen protocol. Briefly, RNA samples were treated 
with DNase (DNA-Free, Ambion, USA) according to manufacturer’s instructions. Reverse 
transcription (RT) reactions were performed with 2 µg of total RNA and random hexamer 
primers using the Thermoscript RT-PCR System (Invitrogen, USA) according to 
manufacturer’s instructions. Real-time PCR reactions were performed using the SYBR 
Green PCR Master Mix (Applied Biosystems, USA) of 24 µl and 1 µl of test cDNA per 
reaction. The primers used for amplification of mouse sialyltransferase genes are given in 
table S1. After an initial denaturation step of 10 min at 95°C, 40 cycles at 95°C for 15 s, 60°C 
  
10 
 
for 1 min and 72°C for 1 min. Gene expression was normalized to GAPDH expression 
calculations were done according to the 2-Ct method (Livak and Schmittgen, 2001). 
Mouse milking - Lactating mothers were separated from their suckling newborns for four 
hours. Milk ejection was stimulated by intraperitoneal injection of 0.5 IU of oxytocin (Sigma, 
Switzerland). Mice were anesthetized by ketamine (0.65 ml/kg) and xylazine (0.5 ml/kg). 
Milk was collected by aspiration (Haberman, 1974; Nagasawa, 1979), then frozen and 
lyophilized. Dry matter was determined by weighing and samples were resuspended in 
water to yield a stock solution of 100 mg/ml. 
Milk oligosaccharide analysis - For each sample an equivalent of 16.5 µg dry matter was 
separated on a CarboPac PA200 analytical column (Dionex, Sunnyvale, CA, USA) with an 
aminotrap guard (Dionex) using a high performance anion exchange chromatography 
system ICS3000 (Dionex) equipped with a pulsed amperometry detector. The column 
compartment was set to 25°C and the flow speed to 0.38 ml/min. The running conditions 
were as follows: isocratic 30 mM NaOH (J.T.Baker, NL) for 10 min followed by a linear 
gradient to 100 mM NaOH for 10 min followed by isocratic 100mM NaOH for 10 min and a 
linear gradient from 0 to 100 mM Na-acetate (Merck, D) for an additional 35 min. Each run 
was preceded by a washing and equilibration step: isocratic 500 mM Na-acetate for 5 min 
followed by isocratic 300 mM NaOH for 10 min followed by isocratic 30mM NaOH for 10 
min. The retention times for 6SL and 3SL were 38.3 min and 38.7 min, respectively. Peak 
identification was done based on retention time comparison with authentic external 
sialyllactose standards (Dextra laboratories, UK) and disappearance of sialyllactose peaks 
upon neuraminidase treatment with simultaneous appearance of N-acetylneuraminic acid. 
For quantification, a standard curve with 50, 100 and 250 ng authentic 6SL and 3Sl 
standards was established before and after injection of five milk samples. 
IgA analysis – Fresh feces pellets were homogenized in PBS containing 0.1 mg/ml trypsin 
inhibitor (Sigma) at 4°C and cleared by centrifugation at 10’000 x g for 10 min. 
Supernatants were serially diluted in PBS containing 0.05% Tween (Fluka)/0.1% BSA 
(Fluka) and 50 l were applied pro well. IgA was determined by sandwich-ELISA using anti-
mouse IgA antibody (BD Biosciences) as coating antibody and biotinylated rat anti-mouse 
IgA antibody (BD Biosciences) as detection antibody. The antibody complex was detected 
using streptavidin-HRP (Sigma Aldrich) and tetramethylbenzidine substrate solution (BD 
Biosciences) at 440 nm in an ELISA plate photometer (Tecan, Switzerland). A purified 
mouse IgA standard (BD Biosciences) was used for quantification.    
DSS induced colitis - Seven week old, sex matched mice were treated with 3.75% (w/v) DSS 
(molecular mass = 36-50 kD; MP Biomedicals, France) in drinking water for 5 days followed 
by a supply of normal water until sacrifice of the animals (Okayasu I, 1990). The lowest 
possible DSS dosage was chosen to achieve acute inflammation within 7 days. Body weight 
and physical activity were monitored daily. Animal pain was kept to a minimum by 
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following the Swiss Animal Protection Ordinance and euthanizing animals reaching less 
than 85% of initial body weight. 
Transepithelial permeability assay - Mice were gavaged with 60 mg/100 g body weight of 
FITC-dextran (MW 3,000-5,000, Sigma) (Napolitano et al., 1996). Mice were sacrificed and 
blood was isolated by cardiac puncture. Serum fluorescence (485/535 nm) was measured 
immediately using a Genios Multi-Detection Microplate Reader (Tecan, Switzerland). 
Concentrations were calculated from standard curves using serial dilutions of FITC-dextran 
in serum. 
Histology – The distal third of the colon was mechanically cleaned, cut longitudinally and 
fixed in 4% paraformaldehyde, then embedded in paraffin. Tissue samples were cut in 
serial 3-μm sections, which were stained with haematoxylin–eosin. Histological 
examination was performed in a blinded fashion. Histological scoring of three sections 
obtained from three sites at 100 μm distance was graded on a scale of 0 (normal 
morphology, no infiltrate) to 8 (loss of crypts in large areas, infiltration of the L. submucosa) 
as described previously (Hausmann et al., 2007). 
Cytokine gene expression - RNA from frozen colon tissue was isolated using the RNeasy 
Protect Mini Kit (Qiagen) according to the manufacturer’s instructions. RT was performed 
with 2 µg total RNA using oligo(dT) primers and an Omniscript RT kit (Qiagen, USA). Real-
time PCR was carried out using SYBR Green JumpStart Taq ReadyMix (Sigma, Switzerland) 
with specific primers for IL-1, IL-6, TNFα, IL-12, IFN- and GAPDH (QuantiTec Primer, 
Qiagen, USA), and CCL2, CCL5, CXCL-1 and COX-2 (Table S1) in a Mx3000P thermocycler 
(Stratagene, USA). Cycling conditions were 40 cycles at 95°C for 15 s, 60°C for 30 s and 72°C 
for 30 s after initial denaturation at 95°C for 10 min. Gene expression was normalized to 
GAPDH expression using the 2-Ct method (Livak and Schmittgen, 2001). 
Lamina propria leukocyte isolation - Colon lamina propria leukocytes were isolated as 
described previously (Lefrançois and Lycke, 2003). Briefly, to detach intraepithelial 
lymphocytes, chopped colon segments were incubated 2 x 30 min at 37°C under constant 
stirring condition in 50 ml of Ca2+- and Mg2+-free Hanks’ balanced salt solution containing 
10 mM HEPES, 2% horse serum, 2 mM DTT and 0.5 mM EDTA. Leukocytes were released by 
additional incubation with 0.5 mg/ml of collagenase type IV (Sigma, Switzerland) and 30 
µg/ml of DNAse I (Sigma, Switzerland) for 2 x 45 min at 37°C and cells were filtered 
through a 40 µm nylon mesh cell strainer.  
Flow cytometry – Cells were stained on ice for 30 min with anti-CD45 APC-Cy7, anti-CD19 
APC, anti-CD3 FITC, anti-Gr.1 PE, anti-TCRγδ PE, anti-TCRβ APC, anti-CD4 PE, anti-CD8β PE,  
anti-CD8α PE-Cy5, anti-CD11c APC, anti-Ly-6G PerCP, anti-Ly-6C APC, anti-F4/80 Alexa488, 
anti-CD11b PE, anti-CD4 PerCP-Cy5, anti-IL-17A PE,  anti-IFNγ FITC, anti-IL17 PE 
antibodies (BD Biosciences, USA) and analyzed with a FACSCanto II flow cytometer (BD 
Biosciences, USA). 
  
12 
 
Bone marrow transfer - Ten week old male WT and St3gal4-/- recipient mice were lethally 
exposed to 9.33 Gy radiations (3.11 Gy/min). Femur and tibia from WT and St3gal4-/- donor 
mice were removed and flushed with RPMI 10% FCS (GIBCO, USA) to harvest BM cells. 
Irradiated recipient mice were reconstituted with 2 x 106 BM cells by intravenous injection 
(Spangrude, 2008). Mice were treated with antibiotics (Borgal® 24 % ad us. vet.,Veterinaria 
AG, Zürich, Switzerland) for 3 weeks.  
Temporal temperature gradient gel electrophoresis – DNA was isolated from freshly isolated 
cecal content using the QIAamp DNA Stool Mini Kit (Qiagen, USA). Bacterial 16S rDNA DNA 
was amplified using the universal primers HDA1-GC 5’-
CGCCCGGGGCGCGCCCCGGGCGGGGCGGGGGCACGGGGGGACTCCTACGGGAGGCAGCAGT-3’ 
and HDA-2 5’-GTATTACCGCGGCTGCTGGCAC-3’ according to Ogier (Ogier et al., 2002). The 
PCR conditions were 30 cycles at 94°C for 30 s, 56°C for 30 s, 72°C for 1 min flanked by an 
initial denaturation at 94°C for 4 min and a final elongation at 72°C for 4 min. PCR products 
were loaded on 8.5% polyacrylamide gels containing 8 M urea and separated by TTGE using 
the D-Code universal mutation detection system (Bio-Rad, USA). Electrophoresis was 
performed in 60 mM Tris-acetate, 30 mM acetic acid and 1.5 mM EDTA first at 20 V for 15 
min followed by at constant voltage of 80 V for 18 hours with a temperature increase of 
0.2°C/h from 66 to 70°C. TTGE profiles were analyzed by using GelCompar II software 
(Applied Maths NV, Belgium). 
Bacterial typisation –TTGE bands were excised from the gels and DNA was diffused over 
night at 4°C in 100 µl H2O. Standard HDA primers were used to reamplify the PCR product 
from 3 µl of eluate. PCR products were purified using QIAquick PCR purification kit 
(Qiagen) and sequenced (Synergene Biotech, Switzerland). The proportion of bacterial 
phyla in intestinal samples was determined by real-time PCR using the SYBR Green 
JumpStart Taq ReadyMix (Sigma) as described for cytokine analysis here above and primer 
pairs specific for the lineages Bacteroidetes, Enterobacteriaceae, Lachnospiraceae, clostridial 
cluster IV and Lactobacillaceae (Table S1). The forward primer specific for the 
Ruminococcaceae species was designed by choosing a stretch of 16S RNA gene sequence 
that was distinctive from the corresponding sequences of other Ruminococcaceae of the 
clostridial cluster IV (Fig. S8). Cycling conditions were 40 cycles at 95°C for 15 s, 66°C for 20 
s and 72°C for 20 s after an initial denaturation at 95°C for 10 min. Quantification values 
were calculated by the 2-Ct method relative to total bacteria 16S rDNA amplification. 
Germ-free colonization - Cecal contents (100 mg) of WT and St3gal4-/- donor mice were 
collected under anaerobic conditions and diluted in 10 ml of anaerobic mineral solution 
containing 5 g/l NaCl, 2 g/l glucose, and 0.3 g/l cysteine-HCl (de Sablet et al., 2009). Three 
to four week old C57Bl/6 germ-free males (Institute of Laboratory Animal Science, 
University of Zürich, Switzerland) were colonized with 200 µl of 1:100-diluted cecal 
microbiota by gavage and kept in isolators for 4 weeks. 
  
13 
 
Statistics - Results were expressed as mean ± SEM. Difference between groups was analyzed 
using one-way ANOVA with Bonferroni’s Multiple Comparison Post-test. Significance was 
accepted for p<0.05. 
Online supplemental material – Fig. S1 shows the mRNA levels of sialyltransferases 
normalized to GAPDH expression in mammary gland tissue. Fig. S2 outlines the 
determination of sialic acid in mouse milk. Fig. S3 shows unchanged T-cell development and 
IgA production in the intestine of St3gal4-/- and St6gal1-/- mice. Fig. S4 shows the normal 
susceptibility of St6gal1-/- mice to DSS-induced colitis. Fig. S5 shows the typing of leukocyte 
subsets in the colon of DSS-treated mice. Fig. S6 outlines the identification of a 
Ruminococcaceae species from TTGE analysis. Fig. S6 shows the intestinal microbiota 
analysis in St6gal1-/- mice. Fig. S8 explains the definition of a PCR primer specific for the 
new Ruminococcaceae species. Table S1 lists the primers used in the present study.  
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FIGURE LEGENDS 
Figure 1. Sialyltransferase gene expression in mouse mammary gland. The relative 
levels of mRNA transcripts encoding the six 2,3 sialyltransferases (St3gal1 to St3gal6) and 
the two 2,6 sialyltransferases (St6gal1 and St6gal2) were measured in virgin mice (mRNA 
levels set to 1), at 1 week postpartum , 2 weeks postpartum and 3 days post-weaning.  Data 
represent the mean ± SEM of 3 mice per time point (N = 3). Similar results were obtained in 
2 independent experiments.  
 
Figure 2. Sialyllactose concentration in mouse milk during lactation. (A) α2,3- (3SL) 
and α2,6- (6SL) sialyllactose in milk from WT, St3gal1-/-, St3gal4-/-, St6gal1-/- mice isolated 
at day 2 postpartum; nd, not detectable. Amounts are given in g per 100 g dried milk (DM). 
Each point represents the mean ± SEM of 3 mice from 2 independent experiments (N = 3). 
(B) α2,3- (3SL) and α2,6- (6SL) sialyllactose were measured in WT milk and (C) in St3gal4-
/- milk throughout lactation. Amounts are given in g per 100 g dried milk (DM). Values are 
given as mean ± SEM of 3 mice from 2 independent experiments (N = 3). 
 
Figure 3. DSS-induced colitis. (A) Seven week old WT mice (● WT), cross-fostered WT 
mice (▲ WT CF), St3gal4-/- mice (● KO) and cross-fostered St3gal4-/- mice (▲ KO CF) were 
fed DSS. (A) Body weight (N = 4-8). (B) Colon length. Values are given as percentage of 
untreated control mice; C, control untreated mice, DSS, DSS-treated mice, CF/DSS, cross-
fostered DSS-treated mice (N = 4-8). Similar results were obtained in 4 independent 
experiments. (C) Intestinal permeability as measured by FITC-dextran in serum from 
control mice and colitogenic mice on day 5 of DSS induced colitis as obtained from 3 
independent experiments (N = 4-8). (D) Microscopic analysis of colon tissues. Colons were 
removed at day 7, fixed, and stained with haematoxylin–eosin. Representative results from 
6 mice out of 2 independent experiments are shown, scale bar = 100 m (E) Histological 
scoring of colitis by evaluation of epithelial damage and extend of leukocyte infiltration as 
previously described (Hausmann et al., 2007). Three mice per group were analyzed in 2 
independent experiments (total 6) and 3 animals in untreated groups. * p<0.05. 
 
Figure 4. Expression of mRNA encoding inflammation markers and chemokines in 
colons of mice at day 7 of DSS treatment. Seven week old WT mice, cross-fostered WT 
mice, St3gal4-/- mice and cross-fostered St3gal4-/- mice were fed DSS.  C, control untreated 
mice, DSS, DSS-treated mice, CF/DSS, cross-fostered DSS-treated mice. mRNA levels were 
measured using the 2 - ∆∆ct method and normalized to the levels of the GAPDH mRNA. Values 
are shown relative to the mRNA levels of untreated control mice. Data are represented by 
mean ± SEM from 4 samples out of 2 independent experiments (N = 8), * p<0.05. 
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Figure 5. Hematopoietic cell infiltration and bone marrow chimera of WT and 
St3gal4-/- mice. Colonic cells were isolated and stained with anti-CD45 APC-Cy7 and 
analyzed by FACS. Mice were analyzed on day 0 (D0), 5 (D5) and 7 (D7) of DSS treatment. 
(A) Representative dot plots of WT, cross-fostered WT mice (WT CF), St3gal4-/- and cross-
fostered St3gal4-/- mice (St3gal4-/- CF) out of 3 independent experiments are shown. The 
percentage of gated cells is indicated at the top left corner of each dot.  (B) Quantitation of 
CD45+ cells in colon infiltrates from 3 independent experiments (N = 4-8), * p<0.05. (C) 
Leukocyte subsets in colons on day 0 (D0), 5 (D5) and 7 (D7) of DSS treatment as obtained 
from 2 independent experiments (N = 3-6), * p<0.05, KO: St3gal4-/-. (D) Body weight of WT 
mice transplanted with St3gal4-/- bone marrow cells (▲, N = 10) and St3gal4-/- mice 
transplanted WT bone marrow cells (●, N = 11) during DSS treatment. Data represent the 
mean ± SEM of 10-11 mice from 2 independent experiments, * p<0.05. 
 
Figure 6. Microbiota analysis in the mouse gastrointestinal tract. Temporal 
temperature gradient gel electrophoresis profiles of 16S rDNA gene amplification products 
from cecum of 6 week-old WT and St3gal4-/- mice fed with either WT or St3gal4-/- milk (A) 
and after DSS induced colitis (B). The data represent the results of 1 out of 2 independent 
experiments with 6 animals per group. The marker (M) shows amplification products from 
the species Lactobacillus plantarum, Lactococcus lactis, Corynebacterium variabile, 
Brevibacterium linens, Arthrobacter protophormiae from top to bottom. Arrows (►) mark 
the position corresponding to the Ruminococcaceae bands.  
 
Figure 7. Quantitative analysis of gastrointestinal microbiota. The microbiota 
composition of WT, St3gal4-/- and respective cross-fostered (CF) mice was determined by 
real-time PCR in (A) native microbiota, and (B) microbiota on day 7 of DSS treatment. (C) 
Real-time PCR of Ruminococcaceae species in WT, St3gal4-/- and CF mice in control 
conditions and after 7 days of DSS induced colitis. Values are shown as relative amount to 
total bacteria 16S rDNA measured by the 2-Ct method. Two independent experiments 
were performed and data show means ± SEM of 4-6 animals (N = 4-6), * p<0.05. 
 
Figure 8. Colitis in reconstituted germ-free mice.  (A) Temporal temperature gradient 
gel electrophoresis profiles of 16S rDNA gene amplification products from feces of mice 
colonized with WT or St3gal4-/- microbiota at two weeks post colonization (N = 6). The 
marker (M) shows amplification products from the species Lactobacillus plantarum, 
Lactococcus lactis, Corynebacterium variabile, Brevibacterium linens, Arthrobacter 
protophormiae from top to bottom. Arrows (►) mark the position corresponding to the 
Ruminococcaceae bands. (B) Body weight change in DSS-induced colitis of reconstituted 
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germ-free mice colonized with WT (▼) or St3gal4-/- (♦) microbiota (N = 6). The difference 
in body weights measured at day 7 was significant (p<0.05). The data show the results from 
1 experiment performed with 6 animals per group (N = 6).  
 
Figure S1. Sialyltransferase gene expression in mouse mammary gland. The levels of 
mRNA transcripts encoding the six 2,3 sialyltransferases (St3gal1 to St3gal6) and the two 
2,6 sialyltransferases (St6gal1 and St6gal2) were normalized to GAPDH expression 
(mRNA levels set to 1) at 1 week postpartum , 2 weeks postpartum and 3 days post-
weaning.  Data represent the mean ± SEM of 3 mice per time point (N = 3). Similar results 
were obtained in 2 independent experiments.  
 
Figure S2. Determination of sialic acid composition in mouse milk. N-acetylneuraminic 
acid  (NeuAc) was identified in mouse milk after neuraminidase treatment while N-
glycolylneuraminic acid (NeuGc) was not detectable. Milk samples before and after 
neuraminidase treatment were separated by pulsed amperometry-HPAEC and compared to 
the following authentic standards: monosaccharides NeuAc, NeuGc and oligosaccharides 
2FL (α1,2 fucosylated lactose), 6SL, 3SL. Similar results were obtained in 3 independent 
experiments.  
 
Figure S3. T-cell markers and IgA in St3gal4-/- and St6gal1-/- mice. (A) The ratios of 
TCRαβ/γδ, CD4/CD8 and CD8αα/αβ CD3+ T-cells were measured in 6-week old WT, 
St3gal4-/-, St6gal1-/- and correspondingly cross-fostered (CF) mice. Values are given as 
mean ±SEM of 4 to 7 measurements from 2 independent experiments. (B) IgA levels were 
measured in feces by ELISA as described in Materials and Methods. Data show means ± SEM 
of 5 mice out of 1 of 2 independent experiments.  
 
Figure S4. DSS-induced colitis in St6gal1-/- mice. Body weight was determined daily in 
WT mice (● solid line) and  St6gal1-/- mice (▲ dashed line). Values represent the mean ± 
SEM of 6 mice per time point (N = 6). Similar results were obtained in 3 independent 
experiments. 
 
Figure S5. Leukocyte typing on day 0 and 7 of DSS treatment. (A) Representative dot-
plot analysis of infiltrating leukocytes in WT and St3gal4-/- mice. Leukocytes were gated as 
CD45+ cells and further subdivided according to the markers CD4, CD8, CD19, Ly6G, F4/80, 
Ly6C and Mac-1. The percentage of CD45+ cells are indicated in the gates and quadrants. 
The corresponding quantitative analysis of 3-6 mice as obtained from 2 independent 
experiments is shown on Fig. 5C. (B) Th1 to Th17 cell ratio in the colon of WT () and 
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St3gal4-/- (▲) mice at day 7 of DSS treatment. Data show the results of 2 independent 
experiments with 4-5 animals per group, * p< 0.005. 
 
Figure S6. Identification of Ruminococcaceae species. PCR was performed from DNA 
bands eluted out of temporal temperature gradient gel electrophoresis using the standard 
HDA-1 and HDA-2 primers (see Materials and Methods). The sequences retrieved from the 
PCR products were aligned using ClustalW2  (www.ebi.ac.uk/ Tools/clustalw2/index.html). 
The consensus sequence (underlined with stars) was searched in the ribosomal database 
project using the seqmatch tool (rdp.cme.msu.edu/seqmatch/ seqmatch_intro.jsp) and 
identified as belonging to the family of Ruminococcaceae. 
 
Figure S7. Microbiota analysis in St6gal1-/- mice. Temporal temperature gradient gel 
electrophoresis profiles of 16S rDNA amplification products from cecum of 6 week-old WT 
and St6gal1-/- mice fed with either normal (WT) or 6SL-deficient (St6gal1-/-) milk. The 
marker (M) shows amplification products from the species Lactobacillus plantarum, 
Lactococcus lactis, Corynebacterium variabile, Brevibacterium linens, Arthrobacter 
protophormiae from top to bottom. The arrows (►) mark the position corresponding to the 
Ruminococcaceae bands described in Fig. 6A. The data represent the results of 1 out of 2 
independent experiments with 6 animals per group.  
 
Figure S8. Definition of a primer specific for the new Ruminococcaceae species. The 
Ruminococcaceae sequence (R. TTGE) identified from the temporal temperature gradient 
gel electrophoresis analysis (see Fig. 6A and Fig. S5) was aligned with 6 16S rDNA 
sequences from known Ruminococcaceae species using the ClustalW2 algorithm. A region of 
partial sequence identity was chosen to design a primer enabling the preferential 
amplification of the Ruminococcaceae species identified in our study (marked with red box).    
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Table S1: List of primers for the amplification of sialyltransferase genes, bacterial 
populations, chemokine and inflammatory marker genes 
Names Primers Sequences 5’-3’ References 
St3Gal1 mQ_S3G-I Fwd CACCTGCAGACACTGCATCAG (present study) 
 mQ_S3G-I Rev TCAGAGCGTTGTGGACTGTCA  
St3Gal2 mQ_S3G-II Fwd CCGAACAACTCACCATTTCATG (present study) 
 mQ_S3G-II Rev GCGCTGGCAATCCACATTA  
St3Gal3 mQ_S3G-III Fwd GGCTACGCTTCAGCCATGA (present study) 
 mQ_S3G-III Rev CCCAAAAGGTGGCACAAACT  
St3Gal4 mQ_S3G-IV Fwd TCCAGGGTGAGGCAGAGAGA (present study) 
 mQ_S3G-IV Rev GTCCCAAAGGGCAGCTCATA  
St3Gal5 mQ_S3G-V Fwd GCAGCCTCCACAGGGACTT (present study) 
 mQ_S3G-V Rev AATAGGACGAAGAGGTGCACAGA  
St3Gal6 mQ_S3G-VI Fwd CCCAAGGATCAGAAACCCAAA (present study) 
 mQ_S3G-VI Rev CATGGTGGCATTCCCGTAGT  
St6Gal1 mQ_S6G-I Fwd GCGCAAGACAGATGTGTGCTA (present study) 
 mQ_S6G-I Rev TCTGTTCCCTCATTGAGATGCTT  
St6Gal2 mQ_S6G-II Fwd CTATGACAGCGACATGCTGTCA (present study) 
 mQ_S6G-II Rev CACCATGCTTGTTGAAGGACAT  
CXCL-1 mCXCL-1 Fwd CTGGGATTCACCTCAAGAACATC (present study) 
 mCXCL-1 Rev CAGGGTCAAGGCAAGCCTC  
COX-2 mCOX-2 Fwd TGAGCAACTATTCCAAACCAGC (present study) 
 mCOX-2 Rev GCACGTAGTCTTCGATCACTATC  
CCL2 mCCL-2 Fwd TTAAAAACCTGGATCGGAACCAA (present study) 
 mCCL-2 Rev GCATTAGCTTCAGATTTACGGGT  
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CCL5 mCCL-5 Fwd TGCTGCTTGCCTACCTC (Laubli et al., 2009) 
 mCCL-5 Rev ACACTTGGCGGTTCCTTC  
Total Bacteria 515F GTGCCAGCMGCCGCGGTAA (Frank et al., 2007) 
 805R GACTACCAGGGTATCTAAT (Dahlgren, 1987) 
Bacteroidetes Bac303R CCAATGTGGGGGACCTTC (Dahlgren, 1987; Frank et 
al., 2007) 
 Bac32F AACGCTAGCTACAGGCTT  
Enterobacteriaceae Eco1457F CATTGACGTTACCCGCAGAAGAAGC (Bartosch et al., 2004) 
 Eco1652R CTCTACGAGACTCAAGCTTGC  
Lachnospiraceae Ccocc1F CGGTACCTGACTAAGAAGC (Rinttilä et al., 2004) 
 Ccocc1R AGTTTYATTCTTGCGAACG  
Clostridial cluster IV Clep866mF TTAACACAATAAGTWATCCACCTGG (Ramirez-Farias et al., 2009) 
 Clept1240mR ACCTTCCTCCGTTTTGTCAAC  
Lactobacillaceae F_Lacto 05 AGCAGTAGGGAATCTTCC (Furet et al., 2009) 
 AR_Lacto 04 CGCCACTGGTGTTCYTCCATATA  
Ruminococcaceae 
species 
Ruminococcaceae CTAGGTGAAGATACTGACGGTAACCTG (present study) 
  HDA-2 GTATTACCGCGGCTGCTGGCAC (Walter et al., 2000) 
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RDP ID# Seqmatch score Annotation
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S001145331 0.880 uncultured bacterium; 1103200819990; EU844046
S000934260 0.840 uncultured bacterium; G08; EU136278
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Primer sequence: CTAGGTGAAGATACTGACGGTAACCTG
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